Yield10 grants Nufarm license to certain Omega-3 intellectual property asset
Nufarm and Yield10 have additionally agreed to immediately negotiate exclusively with each other for the sale of substantially all of Yield10’s remaining assets to Nufarm
Nufarm and Yield10 have additionally agreed to immediately negotiate exclusively with each other for the sale of substantially all of Yield10’s remaining assets to Nufarm
The IPO, with a face value of Rs. 10 each, is a mix of fresh issuance of Rs 750 crore and an offer for sale of up to 36 lakhs equity shares by promoters group selling shareholder
The company posted revenue of Rs. Rs 1,176 crore for the quarter ended June 2024
The certifications pave the way for a large-scale use of the Saipem protocol for the qualification of the performance of materials used in the construction of subsea hydrogen pipelines
BPCL has consistently demonstrated its leadership in the Indian bunkering sector, being the first to introduce IMO 2020 compliant bunker fuel in the country
Standalone operating revenues for chromium chemicals increased by 3% Y-o-Y from. Rs. 249.9 crore in Q1 FY24 to Rs. 258.2 crore in Q1 FY25
Profit before tax tumbled 75.40 per cent to Rs 16.34 crore during the quarter
This program will be on radio, scientists will sit in it, officials of the agriculture department will sit, he will also sit and farmers will be given information about whatever is necessary
The business has continued to tightly control inventory and net working capital
This impressive top-line growth was accompanied by a 142% rise in EBITDA
The Brenntag Group’s operating EBITA came to € 556.8 million in the first half of 2024
The product is well-suited for large-volume applications that require substantial amounts of adhesives or sealants
The export segment's challenges led to a higher volume contribution from bulk chemicals, which impacted our consolidated profitability margins
Compression in the EBITDA margins was largely due to the lower volumes offtake for the quarter
The company posted revenue from operation at Rs. 454.55 crore in Q1 FY25 as compared to Rs. 293.47 crore in Q1 FY24
The company has successfully achieved higher margins by optimising costs and making strategic pricing decisions
The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
Setting up a new plant at Dammam, Saudi Arabia with an approx. cost of Rs 600 crore
We have launched 7 new products this quarter, including 3 in the new Plant Health vertical, which focuses on micronutrient products. Additionally, the company has added 4 products to its existing B2C portfolio
EBITDA including other income for the quarter is Rs. 5.03 crore as against Rs. 2.08 crore in Q1 FY24, mainly due to the increased volume, better realization, and contributions from new CPW production facility
Subscribe to our newsletter & stay updated.